Healthcare | October 20, 2021
NIH grants in-principle accreditation to Advanced Enzymes supplements
The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness
The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness
The division is expected to grow to over a 100-member strong team by 2022
It is the first presbyopia-correcting lens implant for cataract surgery
The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit
U.S. FDA to decide whether to authorize a booster dose in the coming days
The interim analysis showed that the MVC-COV1901 vaccine has a good safety profile and elicits promising neutralising antibody titres
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
This opens up a huge market for the company’s Magnezis implants in India
Subscribe To Our Newsletter & Stay Updated
